TGF-β1 of no avail as prognostic marker in lyme disease

Background. Within the present in vivo study using the wild type mouse strains C3H/HeN and FVB/N it was intended to (1) measure TGF-β1 expression in the course of lyme disease, (2) examine the potential correlation of TGF-β1 expression with the clinical outcome of a Borrelia infection (with a focus...

Full description

Bibliographic Details
Main Author: Julia Schumann
Format: Article
Language:English
Published: PeerJ Inc. 2014-05-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/398.pdf